3 Filters That Separate Breakthrough Devices from Failed Ventures
What truly sets successful medtech apart? Josh Vose, CEO of Tulavi Therapeutics, shares three key lessons from his journey, from focusing only on devices that matter, to choosing the harder regulatory path that builds lasting advantage, to tailoring pitches to the right investors. His perspective offers a clear view into what it takes to move from idea to adoption.